Health Encyclopedia


Health Encyclopedia Home

FDA OKs Drug to Treat Hot Flashes in Menopausal Women

FDA OKs Drug to Treat Hot Flashes in Menopausal Women

FRIDAY, Oct. 4 (HealthDay News) -- Pfizer Inc. says it has gained U.S. approval for a drug designed to treat menopause-related hot flashes and potentially prevent osteoporosis in postmenopausal women who have a uterus.

The United States is the first country to approve the once-a-day tablet called Duavee (conjugated estrogens/bazedoxifene), according to Pfizer. When prescribed just for the prevention of osteoporosis in postmenopausal women, use of Duavee should only be considered for women at significant risk, and non-estrogen medication should be considered first, the drug maker advised.

The U.S. Food and Drug Administration's approval was based on phase 3 clinical trials that included generally healthy, postmenopausal women with a uterus. One study found that women taking the drug had 74 percent fewer moderate-to-severe hot flashes after 12 weeks of treatment, compared with a 47 percent reduction among women who took a placebo, Pfizer said in a news release.

In other trials, women who took Duavee showed increased levels of bone mineral density in the hip and lumbar spine after one and two years of treatment, while women in the placebo group had decreased levels, the drug company said.

Common side effects of Duavee include muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness and neck pain, according to Pfizer.

Pfizer said that Duavee should not be used by women who: have or have had blood clots; are allergic to any of its ingredients; have unusual vaginal bleeding; have or have had certain cancers (e.g. uterine or breast), liver problems, or bleeding disorders; or are pregnant, may become pregnant or are breast-feeding.

Estrogen and drugs like bazedoxifene can increase the risk of blood clots. Women should talk with their doctor about how long to stay on Duavee, Pfizer said.

One expert said women should weigh their options carefully before choosing to take the drug.

"Duavee should be used with caution, and only for the shortest time possible," said Dr. Jennifer Wu, an ob/gyn with Lenox Hill Hospital in New York City. "No hormone replacement is intended for the long term."

"Uterine cancer may still be a risk when using the estrogen," Wu added. "Longer term studies are needed."

More information

The U.S. Office on Women's Health has more about menopause.

SOURCE: Jennifer Wu, M.D., ob/gyn, Lenox Hill Hospital, New York City; Pfizer Inc., news release, Oct. 3, 2013

Related Items
Daily News Feed
  Researchers Describe 1st 'Functional Cure' of HIV in Baby
  Health Tip: Ask Questions About Your Child's Medication
  Common Blood Pressure Drugs May Help Slow Dementia
  In Mice, Diabetes Drug Metformin Tied to Longer, Healthier Lives
  More Drugs Show Promise in Fighting Hepatitis C
  Epilepsy Drug Warnings May Slip Through Cracks
  Hospitals Increasingly Give Powerful Clot-Buster for Stroke
  U.S. Nursing Homes Reducing Use of Antipsychotic Drugs
  Mental and Substance Disorders Major Cause of Nonfatal Illnesses
  Prescription Sleep Aids a Common Choice for American Insomnia
  New Drug Shows Promise for Type 2 Diabetes
  All-in-One Pill May Be Effective Treatment for Heart Care
  Young Americans' Prescription Med Abuse Still Down: Report
  Reality TV Star Discusses Addiction Recovery
  Novel Drug Shows Promise for Early Stage Breast Cancer
  Testosterone Not the Whole Story in 'Male Menopause'
  FDA Approves First 'Pre-Surgical' Drug for Breast Cancer
  'Bath Salts' Drugs Led to 23,000 ER Visits in One Year: U.S. Report
  Opioids Not Winning the Battle Against Pain, Study Suggests
  Health Tip: Can I Take an NSAID?
  Many Kids With Autism on Multiple Medications, Study Finds
  Reports of U.S. Cases of Flesh-Eating Drug Questioned
  Key Safety Questions May Linger for FDA-Expedited Drugs
  New Drug Shows Early Promise in Treating Parkinson's Psychosis
  FDA Announces Moves to Avert Drug Shortages
  Arthritis Drug Could Benefit Some Kidney Disease Patients
  Most Teens Who Misuse Painkillers Aren't After a High, Study Finds
  Study Finds Two Drugs Aren't Better Than One for Kidney Disease
  Fizzy Drugs May Pose a High-Salt Danger, Study Suggests
  OxyContin Tops List of Abused Prescription Drugs: Survey
  FDA Starts Regulating Compounding Pharmacies
  Drug Arimidex Cuts Risk for Breast Cancer in Older, High-Risk Women: Study
  Drug Labels Still Lack Infant Info, Study Finds
  Viagra for Menstrual Cramps?
  2 Pre-Surgery Drug Treatments Show Promise Against Aggressive Breast Cancer
  Glaxo to End Payments to Prescribing Doctors
  Many ADHD Drugs Linked to Painful Erections: FDA
  80 Percent of Cancer Docs Have Faced Drug Shortages: Survey
  Landmark ADHD Study Backed Drugs Over Therapy at a Cost: Report
  Liquid Tamiflu for Kids in Short Supply
  New Drug Combo Might Help Older, Sicker Patients With Leukemia
  Students Smoke Weed Despite Drug Testing at Schools, Study Finds
  Merck Recalls Cholesterol Drug Liptruzet
  FDA Warns Against Prescription Drugs With High Levels of Acetaminophen
  Drug Abusers at Risk for Suicidal Thoughts, Survey Finds
  Design Flaws Plague Many Animal-Based Drug Studies, Researchers Say
  FDA Approval Process Comes Under Scrutiny in Studies
  ERs Not Curbing Overuse of Antibiotics, Study Reveals
  Synthetic Pot Tied to Surge of Emergency Cases
  2 Alzheimer's Drugs Found Ineffective in Clinical Trials
  Health Tip: OTC Medications for Children
  Fatal Car Crashes Involving Pot Use Have Tripled in U.S., Study Finds
  Many Bipolar Patients Take Multiple Psychiatric Meds
  Teens' Energy Drink Habit May Be Linked to Booze, Tobacco, Drug Use
  FDA Advisers Revisit Heart Risks Posed by Painkillers
  FDA Panel Sees No Heart-Safety Advantage With Naproxen
  FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure Risk
  FDA To Step Up Oversight of Indian Drug Makers
  Groups Push FDA to Revoke Approval of Highly Potent Painkiller
  Warfarin Safe for Kidney Patients With Irregular Heartbeat: Study
  Pfizer Recalls Some Antidepressants After Drug Mixup
  Experimental Drug May Boost Leukemia Survival, Without Chemo
  Scientists Explore Better Way to Deliver Treatment for Eye Disease
  FDA OKs Quick-Acting Antidote for Prescription Painkiller Overdose
  Experimental Breast Cancer Drug Seems Safe, Effective for Advanced Disease
  Heart Failure Drug Might Help Reduce Hospitalizations
  FDA Approves New Type 2 Diabetes Drug
  Study Links Casual Marijuana Use to Changes in Brain
  Diabetes Complication Rates Drop Among U.S. Adults
  FDA Approves Under-the-Tongue Hay Fever Pill
  Pot Smoking May Pose Heart Dangers, Study Suggests
  Saturday Is National Drug Take-Back Day
  Tips for New Moms on Mother's Day
  Existing Drugs May Work Against MERS, Studies Suggest
  Sharp Rise in ER Visits Tied to Abuse of Sedative, Study Finds
  Illegal Online Meds Targeted in Worldwide Crackdown, FDA Says
  Kids More Likely Than Adults To Be Resistant to HIV Meds: Study
  Steroids May Not Be Wise Choice for Intensive-Care Patients
  Use Prescription Painkillers Safely
  Medication Safety Essential For Seniors
  Insulin Use, Out-of-Pocket Costs Way Up for Type 2 Diabetes
  Blacks May Respond Better Than Whites to Diabetes Drug Metformin
  Mom's Epilepsy Drugs Appear Safe in Breast Milk
  FDA: Bee Pollen Weight Loss Products Pose Health Risks
  Testosterone Products Must Warn About Risk of Venous Clots: FDA
  Some Acne Products Can Trigger Severe Allergic Reactions: FDA
  FDA Approves Inhaled Diabetes Medication
  Liver Cancer Drug Fails to Live Up to Early Promise
  Prescriptions for Powerful Painkillers Vary Widely Among States: CDC
  Ecstasy Use Tied to Rare Spinal Blood Vessel Problem in Teen
  Researchers Discover How 'Magic Mushrooms' Affect the Brain
  Breast Cancer Drug Aromasin May Be Option for Some Premenopausal Women
  New Eczema Drug Shows Promise in Early Trials
  Don't Judge a Pill by Its Color
  Mississippi Girl Thought Cured of HIV Shows Signs of Infection
  Asthma Drug May Help Those With Chronic Hives